Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.3178 | 95 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.52085 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.43959 | 95 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.34305 | 94 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.3641 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.21628 | 91 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.68736 | 93 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.54009 | 92 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.76345 | 93 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.18628 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.11194 | 94 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.84543 | 93 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.99296 | 93 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.85986 | 93 |